24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Therapix
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
10:29
Intel VP: “We had 11 or 12 layers of management... now it’s 5 or 6”
21:48
From textile recycling to autonomous vessels: The vision behind the Dream Team startups
20:25
ELNET: German business leaders “are looking with admiration and respect towards the Startup Nation”
More stories
Buzz
Most popular
Daily
Weekly
1
Unit 8200 veterans raise $22 million Series A for real-time impersonation defense
2
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
3
Check Point raises $1.75 billion, potentially eyeing AI expansion
4
Nice puts Actimize up for sale at a $1.5-2 billion price tag
5
Hapag-Lloyd eyes ZIM acquisition, workers push back
More news
Therapix
4 stories about Therapix
Cannabis Companies Therapix and Destiny to Merge
28.07.19
|
Adi Pick
The merged company will focus on Therapix's technology and assets pertaining to clinical-stage pharmaceutical applications of cannabis, and will include Destiny's genomics-based cannabis breeding techniques and development capabilities
Cannabis Company Therapix Biosciences to Raise $2.25 Million in Direct Offering
28.03.19
|
Lilach Baumer
In December, Israel-based Therapix scrapped a deal to be acquired by Canadian FSD Pharma for $48 million worth of FSD stock
FSD Pharma’s Acquisition of Therapix Hits a Snag
12.12.18
|
Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed
28.11.18
|
Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market